Search research articles
Contact Us
Filters
Showing results (101-110 of 126) with videos related to
Page
of 13
Sort By:
Blood Cells, Molecules & Diseases
|
November 27, 2016
An oral Hemokine<sup>TM</sup>, α-methylhydrocinnamate, enhances myeloid and neutrophil recovery following irradiation in vivo
Douglas V Faller, Serguei A Castaneda, Daohong Zhou, et al.
Free Radical Biology & Medicine
|
May 22, 2026
Mitoredox Shifts in Mitochondrial Dysfunction
Walter H Moos, Douglas V Faller, Ioannis P Glavas, et al.
Cancers
|
April 30, 2021
Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models
Fabien Muselli, Lucas Mourgues, Rita Morcos, et al.
Mitochondrion
|
August 15, 2023
Epilepsy: Mitochondrial connections to the 'Sacred' disease
Walter H Moos, Douglas V Faller, Ioannis P Glavas, et al.
Plos One
|
December 30, 2015
Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice
Michael S Boosalis, Jose I Sangerman, Gary L White, et al.
Blood
|
November 23, 2006
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies
Susan P Perrine, Olivier Hermine, Trudy Small, et al.
Investigational New Drugs
|
May 22, 2018
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors
A Craig Lockhart, Todd M Bauer, Charu Aggarwal, et al.
Leukemia
|
June 25, 2021
A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis
Angela Dispenzieri, Efstathios Kastritis, Ashutosh D Wechalekar, et al.
Blood Cells, Molecules & Diseases
|
June 7, 2011
Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo
Michael S Boosalis, Serguei A Castaneda, Marie Trudel, et al.
Journal of Hematology & Oncology
|
May 11, 2022
Pevonedistat in East Asian patients with acute myeloid leukemia or myelodysplastic syndromes: a phase 1/1b study to evaluate safety, pharmacokinetics and activity as a single agent and in combination with azacitidine
Hiroshi Handa, June-Won Cheong, Yasushi Onishi, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 126) with videos related to
Sort By:
Page
of 13
Blood Cells, Molecules & Diseases
|
November 27, 2016
An oral Hemokine<sup>TM</sup>, α-methylhydrocinnamate, enhances myeloid and neutrophil recovery following irradiation in vivo
Douglas V Faller, Serguei A Castaneda, Daohong Zhou, et al.
Free Radical Biology & Medicine
|
May 22, 2026
Mitoredox Shifts in Mitochondrial Dysfunction
Walter H Moos, Douglas V Faller, Ioannis P Glavas, et al.
Cancers
|
April 30, 2021
Combination of PKCδ Inhibition with Conventional TKI Treatment to Target CML Models
Fabien Muselli, Lucas Mourgues, Rita Morcos, et al.
Mitochondrion
|
August 15, 2023
Epilepsy: Mitochondrial connections to the 'Sacred' disease
Walter H Moos, Douglas V Faller, Ioannis P Glavas, et al.
Plos One
|
December 30, 2015
Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice
Michael S Boosalis, Jose I Sangerman, Gary L White, et al.
Blood
|
November 23, 2006
A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies
Susan P Perrine, Olivier Hermine, Trudy Small, et al.
Investigational New Drugs
|
May 22, 2018
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors
A Craig Lockhart, Todd M Bauer, Charu Aggarwal, et al.
Leukemia
|
June 25, 2021
A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis
Angela Dispenzieri, Efstathios Kastritis, Ashutosh D Wechalekar, et al.
Blood Cells, Molecules & Diseases
|
June 7, 2011
Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo
Michael S Boosalis, Serguei A Castaneda, Marie Trudel, et al.
Journal of Hematology & Oncology
|
May 11, 2022
Pevonedistat in East Asian patients with acute myeloid leukemia or myelodysplastic syndromes: a phase 1/1b study to evaluate safety, pharmacokinetics and activity as a single agent and in combination with azacitidine
Hiroshi Handa, June-Won Cheong, Yasushi Onishi, et al.
Page
of 13